1. Home
  2. SLNO vs NCNO Comparison

SLNO vs NCNO Comparison

Compare SLNO & NCNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLNO
  • NCNO
  • Stock Information
  • Founded
  • SLNO 1999
  • NCNO 2011
  • Country
  • SLNO United States
  • NCNO United States
  • Employees
  • SLNO N/A
  • NCNO 1833
  • Industry
  • SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • NCNO Computer Software: Prepackaged Software
  • Sector
  • SLNO Health Care
  • NCNO Technology
  • Exchange
  • SLNO Nasdaq
  • NCNO Nasdaq
  • Market Cap
  • SLNO 3.8B
  • NCNO 3.2B
  • IPO Year
  • SLNO 2014
  • NCNO 2020
  • Fundamental
  • Price
  • SLNO $68.57
  • NCNO $29.08
  • Analyst Decision
  • SLNO Strong Buy
  • NCNO Buy
  • Analyst Count
  • SLNO 10
  • NCNO 16
  • Target Price
  • SLNO $112.50
  • NCNO $31.33
  • AVG Volume (30 Days)
  • SLNO 1.6M
  • NCNO 1.3M
  • Earning Date
  • SLNO 08-06-2025
  • NCNO 08-26-2025
  • Dividend Yield
  • SLNO N/A
  • NCNO N/A
  • EPS Growth
  • SLNO N/A
  • NCNO N/A
  • EPS
  • SLNO N/A
  • NCNO N/A
  • Revenue
  • SLNO $32,656,999.00
  • NCNO $556,707,000.00
  • Revenue This Year
  • SLNO N/A
  • NCNO $9.70
  • Revenue Next Year
  • SLNO $209.31
  • NCNO $8.80
  • P/E Ratio
  • SLNO N/A
  • NCNO N/A
  • Revenue Growth
  • SLNO N/A
  • NCNO 13.39
  • 52 Week Low
  • SLNO $41.50
  • NCNO $18.75
  • 52 Week High
  • SLNO $90.32
  • NCNO $43.20
  • Technical
  • Relative Strength Index (RSI)
  • SLNO 32.58
  • NCNO 57.84
  • Support Level
  • SLNO $66.72
  • NCNO $27.38
  • Resistance Level
  • SLNO $87.17
  • NCNO $28.25
  • Average True Range (ATR)
  • SLNO 3.81
  • NCNO 0.81
  • MACD
  • SLNO -1.52
  • NCNO 0.14
  • Stochastic Oscillator
  • SLNO 21.55
  • NCNO 98.87

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

About NCNO nCino Inc.

Ncino Inc is a provider of cloud-based software for financial institutions. Its software solution digitizes, automates, and streamlines inefficient and complex processes & workflows and utilizes data analytics & artificial intelligence that enables financial institutions to onboard new clients, make loans, and manage the entire loan life cycle, open deposits, and other accounts, and manage regulatory compliance. It also offers professional services, including configuration & implementation, training, and advisory services. The company generates the majority of its revenue from subscription services. The company caters to financial institutions, enterprise banks, regional banks, community banks, and credit unions. The vast majority of its revenue comes from the United States.

Share on Social Networks: